• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim

Men rowing on a river
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 15th May 2018

Making Outcome-based Payments a Reality in the NHS: A Research Collaboration between OHE, RAND Europe and King’s College London

OHE, in collaboration with RAND Europe and King’s College, has been awarded a research grant from Cancer Research UK exploring outcome-based payments. OHE, in collaboration with RAND Europe and King’s College London, has been awarded a research grant from Cancer…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE, in collaboration with RAND Europe and King’s College, has been awarded a research grant from Cancer Research UK exploring outcome-based payments.

OHE, in collaboration with RAND Europe and King’s College London, has been awarded a research grant from Cancer Research UK in partnership with Greater Manchester Health & Social Care Partnership (GMHSCP). The aim of the research is to explore the evidence base for an outcome-based payments system for cancer drugs.
 
Can we create a model of paying for new cancer drugs on the basis of the outcomes they achieve? This question was raised by Cancer Research UK, in a Research Brief (PDF), as a potential way of addressing the challenges faced by health care in England, including the NHS’s unprecedented financial challenges, current advances in the development of new precision treatments for cancer, NICE recommendations being increasingly based on immature data, increasing use of real-world evidence in clinical settings, and the right of cancer patients to have quicker access to innovative evidence-based cancer drugs.
 
The Office of Health Economics, RAND Europe, and King’s College London have been awarded a research grant from Cancer Research UK in partnership with Greater Manchester Health & Social Care Partnership. The research team will assist Cancer Research UK in taking the first steps to meeting the challenge, which will involve undertaking a comprehensive review of the literature to find out what outcomes are currently being measured in real-world settings globally, including where outcomes-based payments systems are already in place. This phase will be complemented by qualitative research with patients, clinicians, and commissioners, as well as other key stakeholders with the aim of identifying measurable outcomes that can reflect the value of new drugs through the use of real-world evidence.
 
The joint research team has a wealth of experience in the study of cancer outcomes and their potential linkage to payment arrangements.
 
OHE’s team includes:
  • Paula Lorgelly, who has expertise in the economics of cancer (e.g. survivorship, precision medicine and reimbursement) and cancer patient-reported outcomes (e.g using quality-adjusted life years, comparing generic versus condition-specific measures and discrete choice experiments)
  • Patricia Cubi-Mollá, experienced in the analysis of adaptation to chronic illnesses, outcome measures and patient experience; and
  • Amanda Cole, who has led or contributed to projects relating to improving efficiency and resource allocation in cancer care, expediting access to new medicines through adaptive pathways, analysing data governance requirements for real-world data, and using real-world evidence to facilitate managed entry agreements.
  • Adrian Towse and Nancy Devlin will apply their expertise on value-based pricing/reimbursement and patient-reported outcomes by advising the research team throughout the project’s development. The members of the OHE team are also undertaking related research on cancer patient-reported outcomes, as detailed in our blog.
 
RAND Europe’s team is led by their Chief Economist Jon Sussex, whose work has included value-based reimbursement of medicines and the national evaluation of Payment by Results in the NHS; Miaoqing Yang and Jack Pollard, who are health economists with research experience in health care policy evaluation using both quantitative and qualitative methods. Sonja Marjanovic will provide expert advice on understanding the interface between health research and innovation.
 
Prof Richard Sullivan, from the Institute of Cancer Studies, King’s College London, will act as an expert adviser offering insights on clinical cancer outcomes and cancer care.
 
This research will support a better understanding of what is of ‘value’ in the treatment of cancer patients that can be measured in practice, and will generate an evidence base which can inform decision-makers such GMHSCP, the Department of Health, NHS England and NICE. Depending on the results of the study we can provide recommendations on whether to consider outcome-based payments as a flexible pricing mechanism that could be adopted across the NHS in England.  
 
For more information please contact Patricia Cubi-Molla. 
 
  • Research
  • Economics of Innovation
  • Grants

Related News

Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • October 2020

Opportunities to Increase Efficiency in Healthcare

Read more
  • News
  • June 2020

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

Read more
  • News
  • May 2020

Indication-Based Pricing: Are We All Onboard?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!